rsks-1 Antibody

Clarification of Terminology

The term "rsks-1" refers to a gene encoding ribosomal S6 kinase (S6K) in Caenorhabditis elegans. This enzyme is a downstream target of the TOR (Target of Rapamycin) pathway and plays roles in growth, metabolism, and longevity. The term "rsks-1 Antibody" likely refers to antibodies targeting the S6K protein for research purposes (e.g., Western blotting, immunoprecipitation).

Key Context from Search Results:

• S6K (rsks-1) mutations extend lifespan in C. elegans by activating AMPK (aak-2) and modulating stress resistance (Selman et al., 2009) .

• Proteomic studies identified ARGK-1 (arginine kinase) as a critical effector of rsks-1/S6K-mediated longevity .

Relevance of rsks-1 Antibodies in Research

While rsks-1 antibodies are not explicitly mentioned in the provided sources, their utility can be inferred from studies involving S6K detection:

Limitations and Research Gaps

1. No Direct Data on Antibodies: The provided sources focus on rsks-1 genetic mutants, RNAi knockdowns, or downstream effectors (e.g., ARGK-1, AAK-2). Antibody-based tools are not discussed.

2. Commercial Availability: Antibodies targeting rsks-1/S6K would likely be sourced from vendors like Cell Signaling Technology or Santa Cruz Biotechnology, but this is beyond the scope of the provided literature.

3. Alternative Detection Methods:

   • RNAi: Used to knock down rsks-1 expression in tissue-specific studies .

   • Proteomics: Spectral counting identified ARGK-1 as a key rsks-1 effector .

Synergistic Longevity with Insulin/IGF-1 Pathway

Combining rsks-1 (S6K) and daf-2 (IGF-1 receptor) mutations in C. elegans yields a 5-fold lifespan extension, mediated by AMPK and DAF-16/FOXO .

Tissue-Specific Roles

• Germline: Germline-specific rsks-1 RNAi extends lifespan in daf-2 mutants .

• Pharynx: rsks-1 expression in pharynx regulates MWCNT nanoparticle toxicity .